Product Overview

Oflox TZ is a prescription antibiotic medication formulated by Cipla Limited for the treatment of acute diarrhea and dysentery caused by susceptible microorganisms. The product combines two well‑studied anti‑infective agents, Tinidazole and Ofloxacin, in a fixed‑dose tablet that delivers a synergistic effect against anaerobic and gram‑negative bacterial pathogens. Each strip contains ten tablets, and the medication is marketed in pack sizes of 30, 60, or 90 tablets to accommodate varying treatment courses. Oflox TZ is indicated for adult patients experiencing watery, bloody, or mucoid stools associated with travel‑related or endemic gastrointestinal infections. The formulation is intended for oral administration and should be used only under medical supervision.

What is Oflox TZ

Oflox TZ belongs to the class of nitro‑imidazole and fluoroquinolone antibiotics. Tinidazole provides activity against anaerobic bacteria and certain protozoa, while Ofloxacin offers bactericidal action against a broad spectrum of gram‑negative and gram‑positive organisms. The combination is designed to address mixed‑flora infections that commonly underlie severe diarrheal episodes, particularly those complicated by dysentery. As a pharmaceutical product, Oflox TZ is manufactured under strict Good Manufacturing Practice (GMP) standards by Cipla, a globally recognized generic drug producer. The active ingredients are present in a 500 mg/200 mg ratio, ensuring adequate systemic exposure to eradicate pathogenic microbes from the intestinal lumen.

Uses and Benefits

The primary clinical use of Oflox TZ is the rapid resolution of acute bacterial and protozoal diarrhea, especially when laboratory testing confirms the presence of organisms such as Entamoeba histolytica, Giardia lamblia, or susceptible strains of Campylobacter, Shigella, and Salmonella. Patients often experience relief from symptoms like abdominal cramping, fever, and frequent watery stools within 48–72 hours of initiating therapy. In addition to its therapeutic benefits, the fixed‑dose combination improves adherence by reducing the number of pills taken daily, which can enhance completion of the prescribed treatment course. The medication is also associated with a lower incidence of treatment‑failure when compared with monotherapy regimens for certain mixed infections, as demonstrated in clinical studies indexed by the National Center for Biotechnology Information (NCBI).

How It Works

Following oral ingestion, the tablet disintegrates in the gastrointestinal tract, releasing Tinidazole and Ofloxacin into the intestinal fluid. Tinidazole undergoes metabolic activation within anaerobic organisms, generating reactive intermediates that damage DNA and ultimately cause microbial death. Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and repair. The dual mechanism creates a bactericidal environment that is effective against both obligate anaerobes and aerobic gram‑negative pathogens. This complementary action reduces the likelihood of resistance development and provides a broad therapeutic window for patients with compromised gut flora. The absorption of both agents is optimized at acidic pH, and food does not significantly alter their bioavailability, allowing for consistent dosing regardless of meal timing.

Dosage Guidelines

Adults are typically advised to take one tablet of Oflox TZ (containing 500 mg Tinidazole and 200 mg Ofloxacin) twice daily, preferably with a full glass of water, for a treatment duration of three days. The exact regimen may be adjusted based on the severity of the infection, patient age, renal function, and concomitant medical conditions. Patients with moderate hepatic impairment should be monitored closely, as dose modification may be required. It is important to complete the full course even if symptoms improve early, to prevent relapse or the emergence of resistant organisms. For patients with a known hypersensitivity to either Tinidazole or Ofloxacin, alternative therapies should be considered. Always consult a qualified healthcare professional before initiating treatment, and refer to the prescribing information for detailed dosing recommendations.

Side Effects

Like all pharmaceutical products, Oflox TZ may be associated with adverse reactions. The most commonly reported side effects include gastrointestinal disturbances such as nausea, abdominal discomfort, and mild diarrhea, as well as headache, dizziness, and transient metallic taste. Rare but serious adverse events can involve hepatotoxicity, neutropenia, or allergic skin reactions. Patients should discontinue the medication and seek immediate medical attention if they experience severe abdominal pain, persistent vomiting, signs of anaphylaxis (e.g., swelling of the face or throat, difficulty breathing), or unexplained bleeding. A comprehensive list of potential side effects is available on authoritative drug databases such as Drugs.com and the FDA’s medication guide portal.

Warnings and Precautions

Before prescribing Oflox TZ, clinicians should assess patient history for known hypersensitivity to nitro‑imidazole or fluoroquinolone agents, as cross‑reactivity may occur. Caution is advised in individuals with a history of tendon disorders, myasthenia gravis, or prolonged QT interval, since fluoroquinolones have been linked to an increased risk of tendon rupture and cardiac arrhythmias. Concomitant use with other QT‑prolonging medications should be avoided. Patients with severe renal impairment may require dose adjustment, and the medication is generally not recommended for use in pregnancy unless the benefits outweigh the risks. Additionally, Oflox TZ should be used with care in lactating women, as both active ingredients are excreted in breast milk. Always review the full product labeling and consult a healthcare provider for personalized guidance.

Frequently Asked Questions

Q1: Can Oflox TZ be used for viral gastroenteritis?
A: No. Oflox TZ is an antibacterial and anti‑protozoal agent and does not treat viral infections. It should only be used when a bacterial or protozoal cause of diarrhea is confirmed or strongly suspected.

Q2: How quickly does Oflox TZ start working?
A: Most patients report symptom relief within 48 to 72 hours after the first dose. Full eradication of the pathogen may require completion of the entire prescribed course.

Q3: Is it safe to take Oflox TZ with alcohol?
A: Alcohol consumption is not contraindicated but may exacerbate side effects such as dizziness and headache. Patients are advised to limit alcohol intake during treatment.

Q4: Can Oflox TZ be purchased over the counter?
A: No. Oflox TZ is a prescription medication and requires a valid medical prescription from a licensed healthcare professional.

Q5: Where can I find more detailed prescribing information?
A: Detailed prescribing information, including dosing adjustments for renal or hepatic impairment, is available on the FDA’s drug label database, as well as on authoritative sites such as MedlinePlus and the National Institutes of Health (NIH) medication guide.

Related Products

• Misoprost 600 mcg (Misoprostol)
• Misoprost (Misoprostol)
• Misoprost 200 mcg (Misoprostol)
• Misoprostol 600 mcg (Generic)
• Misoprostol 200 mcg (Generic)
• Pantosec D SR (Pantoprazole/Domperidone)
• Pantosec D 50 Mg (Pantoprazole/Domperidone)
• Rabicip 10 mg (Rabeprazole)
• Rabicip (Rabeprazole)
• Pantosec 40 mg (Pantoprazole)
• Rabicip 20 mg (Rabeprazole)
• Rabeprazole 20 mg (Generic)